Indications for Biological Treatment Combined with Allergen-Specific Immunotherapy: Who Is It Really Intended for? (PubMed, J Clin Med) - Sep 27, 2026 - "In order to enhance the efficacy and safety of allergen immunotherapy, biological agents such as omalizumab and dupilumab have been introduced. Research is also underway on the use of dupilumab in patients with multiple food allergies and as an adjunct therapy to oral immunotherapy in patients with cow's milk protein allergy. Further studies are needed to determine the optimal dosing and duration of biological therapy in combination with AIT, as well as to identify patients who may benefit most from such treatment regimes."
Journal • Review • Allergic Rhinitis • Allergy • Asthma • Food Hypersensitivity • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases
|